Patents by Inventor Lars Fredrik Nordstroem

Lars Fredrik Nordstroem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9593078
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: March 14, 2017
    Assignee: AbbVie Inc.
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars Fredrik Nordstroem
  • Publication number: 20150322047
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
    Type: Application
    Filed: May 8, 2015
    Publication date: November 12, 2015
    Applicant: AbbVie Inc.
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars Fredrik Nordstroem
  • Publication number: 20150322108
    Abstract: The present invention features crystalline forms of Compound I.
    Type: Application
    Filed: May 9, 2014
    Publication date: November 12, 2015
    Inventors: Colleen C. Garrett, Lars Fredrik Nordstroem, Donghua Zhu
  • Patent number: RE48923
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-10.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: February 8, 2022
    Assignee: AbbVie Inc.
    Inventors: Jean-Christophe Califano, Michael G. Fickes, Lars Fredrik Nordstroem